GlassScriptPhysician profile
Vasishta M Patel
NPI 1467510990
$3,822.47
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,729 · 2020: $489 · 2021: $1,020 · 2022: $200 · 2023: $202 · 2024: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $384.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $757.34 | 2019-2021 | |
| Emd Serono, INC. | $477.88 | 2019-2023 | Mavenclad |
| Novartis Pharmaceuticals Corporation | $463.46 | 2019-2023 | |
| Eisai INC. | $337.32 | 2019-2021 | |
| Abbvie INC. | $245.34 | 2021-2023 | |
| Biogen, INC. | $243.82 | 2019-2022 | |
| Ucb, INC. | $214.67 | 2019-2021 | |
| Lilly USA, LLC | $208.60 | 2019-2024 | Kisunla, Amyvid |
| Grifols USA, LLC | $200.02 | 2019 | |
| Amgen INC. | $140.99 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $126.72 | 2021 | |
| Upsher-Smith Laboratories LLC | $80.20 | 2019 | |
| Supernus Pharmaceuticals, INC. | $79.88 | 2020-2023 | Qelbree |
| Sk Life Science, INC. | $67.91 | 2020 | |
| Catalyst Pharmaceuticals, INC. | $37.35 | 2020-2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $33.16 | 2019 | |
| Merck Sharp & Dohme LLC | $28.85 | 2021 | |
| Lundbeck LLC | $22.99 | 2020 | |
| Vertical Pharmaceuticals, LLC | $21.11 | 2019 | |
| Genzyme Corporation | $19.30 | 2019 | |
| Acadia Pharmaceuticals INC | $15.56 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasishta Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.